Clinical Trials Logo

Thyrotoxicosis clinical trials

View clinical trials related to Thyrotoxicosis.

Filter by:

NCT ID: NCT02886949 Recruiting - THYROTOXICOSIS Clinical Trials

The Association Between Autoimmune or Inflammation and Thyroid Disease

Start date: November 2011
Phase:
Study type: Observational

This study aims to evaluate the effects of thyroid functions on energy homeostasis and inflammation.

NCT ID: NCT02767245 Completed - Thyrotoxicosis Clinical Trials

Thiamine Supplement in Patients With Severe Hyperthyroidism

Start date: January 2014
Phase: N/A
Study type: Interventional

Thyrotoxicosis is a hypermetabolic state in which there is increased utilization of thiamine. Thiamine deficiency has been observed in association with hyperthyroidism. Several studies documented that thiamine treatment could improve signs and symptoms of congestive heart failure, or even improve left ventricular ejection fraction in patients without thyrotoxicosis. This pilot study aims to evaluate prevalence of thiamine deficiency and assess improvement of cardiovascular function after receiving thiamine supplement in thyrotoxic patients.

NCT ID: NCT02645786 Completed - Heart Diseases Clinical Trials

Thyrotropin Over-suppression and Heart

Start date: September 2009
Phase: N/A
Study type: Observational

The investigators evaluated the cardiac effects of Thyroid-stimulating hormone (TSH) over-suppression in women with differentiated thyroid cancer (DTC) frequently encountered during suppression therapy.

NCT ID: NCT01436994 Completed - Clinical trials for Paediatric Thyrotoxicosis

Antithyroid Drug Treatment of Thyrotoxicosis in Young People

Start date: July 2004
Phase: Phase 3
Study type: Interventional

The investigators aim to establish whether biochemical control during anti-thyroid drug therapy in young people with thyrotoxicosis varies depending upon whether a 'block and replace' or 'dose titration' regimen is used. The investigators will also assess remission rates and the frequency of side-effects in the two treatment groups.

NCT ID: NCT01227499 Completed - Graves Disease Clinical Trials

Differential Diagnosis of STA-PSV in Thyrotoxicosis

Start date: June 2010
Phase: N/A
Study type: Observational

Aim: Graves's disease and thyroiditis can both characterized with thyrotoxicosis, but their clinical outcome and therapy is quiet different. Measurement of iodine uptake is the gold standard to differential diagnosis the thyroiditis or Graves's disease. But the iodine uptake is limited for its availability in china and easily influenced by medicine or food contained iodine.The blood pattern of thyroid CFDS is useful for differentiate the cause of thyrotoxicosis.Most previous studies using the descriptive pattern of thyroid CFDS is easily varied by operator subjective judgement. This study is focus on the role of peak systolic velocity of thyroid superior artery in differential diagnosis of thyrotoxicosis. Methods: Patients with thyrotoxicosis symptoms without recent medicine history were enrolled in two clinical center. Its thyroid function, iodine uptake , CFDS of thyroid and peak systolic velocity of thyroid superior artery is detected. Thyrotoxicosis is defined as TSH level below the low value of normal range. Graves disease is defined as the typical symptoms of graves disease such as graves ophthalmopathy or increased iodine uptake. Thyroiditis is defined as lack of typical symptoms of graves disease or decreased iodine uptake.We use receiver operator curve(ROC) to evaluate its diagnosis value